Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare® Names Frank Sparacino SVP Investor Relations and Corporate Development
“Frank is the ideal candidate to take on this important new role with
Sparacino comes to TRHC from First Analysis, headquartered in
When asked what brought Sparacino to TRHC, Sparacino said, “I think highly of the team, the company’s mission, and the long-term market potential around the medication safety solutions TRHC has developed. I am excited about this new role and the opportunity to join an innovative healthcare technology company that is also a market maker with their medication safety science.”
Prior to First Analysis, Sparacino held positions with
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
T: (215) 870-0829
T: (866) 648-2767
T: (856) 912-5714
Source: Tabula Rasa HealthCare, Inc.